VRDN Viridian Therapeutics, Inc. Загрузка... : Бычьи и медвежьи мнения аналитиков
Загрузка графика...
Лучшие сигналы
Лента
23:02
03 авг
03 авг
Four biotechs flagged as potential buyout targets
Author flags VRDN, OKUR, ELVN, and EWTX as potential acquisition targets based on Novartis Denver flight activity; notes ELVN HQ move and suspicious price action, but no directional commitment.
Низ.
22:56
03 авг
03 авг
Denver flights flag potential biotech M&A targets
Flags four biotechs as possible M&A targets from Novartis's unusual Denver flight activity; notes ELVN is the one already moving.
Низ.
12:27
29 июн
29 июн
Premarket movers include Magnificent Seven stocks all higher, Comcast up 22% on spin-off plans.
Premarket movers include Magnificent Seven stocks all higher, Comcast up 22% on spin-off plans, Doximity down 4% on BofA downgrade, Iridium up 20% on Rocket Lab acquisition, Martin Marietta down 3% on deal, and Viridian up 14% on FDA approval.
19:20
11 мая
11 мая
Institutions bought shares at $17.00 in an upsized offering and are locked from selling until $26; stock currently trades at $16.89. This creates a “floor” below the offering price, and the June 30 PDUFA for veligrotug is a binary catalyst that could send the stock to $34+. Buy the dip below institutional entry; the setup offers both downside protection (institutional floor) and upside optionality (FDA approval). FDA denial or delay on June 30; negative clinical or safety readouts; broader biotech selloff; dilution risk from the convertible notes (conversion at $24.65).
Выс.
Об аналитическом покрытии VRDN
Buzzberg отслеживает VRDN (Viridian Therapeutics, Inc.) в 3 источниках. Бычьих сигналов: 1, медвежьих: 0, от 3 аналитиков. Сентимент преимущественно бычий (25%). Всего отслеживаются 4 торговые идеи. Последние спикеры: seedy19tron, zerohedge, u/Buy-NVDA.